Your search for

56 results were returned

  1. Twobirds news
    30 May 2019
    International team advises Chiesi Farmaceutici on in-licence of Raxone® from Santhera
    www.twobirds.com/en/news/press-releases/2019/uk/international-team-advises-chiesi-farmaceutici-on-inlicence-of-raxone-from-santhera

    International law firm Bird & Bird has advised Chiesi Farmaceutici S.p.A. ("Chiesi") on the in-licence of Raxone® -- an orphan drug used in the treatment of Leber's hereditary optic neuropathy ("LHON")

  2. Twobirds news
    13 May 2020
    Bird & Bird advised Materia on its acquisition of German licensed medicinal cannabis distributor Cannaktiv
    www.twobirds.com/en/news/press-releases/2020/germany/bird-beraet-materia-beim-erwerb-von-cannaktiv

    Bird & Bird LLP advised Materia on the acquisition of all shares in German licensed medicinal cannabis distributor Cannaktiv GmbH. The deal provides Materia – an international manufacturer and distributor of medicinal ...

  3. Twobirds news
    01 June 2020
    Bird & Bird law firm advised Indian vaccine manufacturer Serum Institute of India Pvt. Ltd (part of Cyrus Poonawalla Group) on the sale of Czech unit, Praha Vaccines a.s., to Novavax AB
    www.twobirds.com/en/news/press-releases/2020/czech-republic/bird-and-bird-law-firm-advised-indian-vaccine-manufacturer-serum-institute-of-india-pvt-ltd

    Bird & Bird law firm advised Indian vaccine manufacturer Serum Institute of India Pvt. Ltd (part of Cyrus Poonawalla Group) on the sale of Czech unit, Praha Vaccines a.s., to Novavax AB, subsidiary of Novavax Inc, US ...

  4. Legal news
    07 October 2019
    Dutch competition authority ACM publishes a sector report on the impact of biosimilars on competition between TNF-alfa inhibitors
    www.twobirds.com/en/news/articles/2019/netherlands/dutch-competition-authority-acm-publishes-a-sector

    The Dutch competition authority, ACM, initiated a market study in 2018 into the effect of the introduction of biosimilars on the competition between TNF alfa inhibitors. TNF-alfa inhibitors are biological medicines that ...

  5. Legal news
    12 November 2019
    PI for Tadalafil Dosage Patent refused in Italy
    www.twobirds.com/en/news/articles/2019/italy/pi-for-tadalafil-dosage-patent-refused-in-italy

    By decisions dated 30 July 2018, then confirmed in the appeal by decisions dated 30 August 2018, the Court of Milan dismissed PI requested by ICOS and its licensee Eli Lilly against Sandoz, ascertaining the prima facie ...

  6. Legal news
    07 February 2019
    German Federal Patent Court denies request for preliminary grant of a compulsory license – Where do we go from here?
    www.twobirds.com/en/news/articles/2019/germany/german-federal-patent-court-denies-request-for-preliminary-grant-of-compulsory-license

    Sanofi sought a compulsory licence for the distribution of its high cholesterol drug Praluent® but this was dismissed in preliminary proceedings (docket no: 3 LiQ 1/18).

  7. Legal news
    04 November 2019
    Are German Courts the “Spoilsport” of the “Divisional Game” when it comes to Preliminary Injunction Requests?
    www.twobirds.com/en/news/articles/2019/germany/are-germany-courts-the-spoilsport-of-the-divisional-game-when-it-comes-to

    If a patentee undertakes actions with respect to a patent of the same patent family (e.g. waiving the parent patent of a divisional patent), this is often negatively characterised as playing the “Divisional Game”. We ...

  8. Legal news
    30 September 2019
    Bird & Bird secures win in preliminary injunction patent case before the Düsseldorf Courts
    www.twobirds.com/en/news/articles/2019/germany/bird-and-bird-secures-win-in-preliminary-injunction-patent-case-before-the-dusseldorf-courts

    On September 26, 2019, the Higher Regional Court of Düsseldorf confirmed on appeal that Teva Pharmaceutical Industries Ltd. (“Teva”) – one of Bird & Bird’s key clients – is entitled to a preliminary injunction against ...